Arkeon, a Company Turning Carbon Dioxide Into Protein, Files for Insolvency

Arkeon, an Austrian startup focused on using fermentation to convert carbon dioxide into high-quality amino acids, has officially filed for insolvency. Co-founder and CEO Gregor Tegl announced the news on LinkedIn, expressing gratitude to the team, advisors, investors, and supporters. Despite Arkeon's innovative approach to transforming industrial emissions into proteins and its promising bioprocess technology, the startup faced challenges leading to its insolvency.

Since its establishment, Arkeon had received significant funding from investors and set up a pilot production plant in Vienna to develop its bioreactor system. While the company had plans for large-scale commercial production, it ultimately had to shut down. Tegl remains optimistic about the potential of sustainable biotechnologies, reflecting on the lessons learned from Arkeon's journey as he looks towards the future.